Antibiotics, Not Vaccines, Create Most Adverse Events
With the success of vaccines eliminating potential serious diseases, many parents no longer have contact with vaccine-preventable illnesses.
And, some parents have difficulty balancing the potential harms and benefits of vaccines.
Vaccines, like any medicine, can have side effects, says the FDA.
Most of the vaccine safety initiatives around adverse drug events (ADEs) describe the technological advances which have led to research studies focused on the safety of existing vaccines and have sometimes created a climate of concern.
An adverse event following immunization is defined as any untoward medical occurrence which follows immunization and which does not necessarily have a causal relationship with the usage of the vaccine.
In a recent study, vaccines were reported to account for 19.5 percent of ADEs for children aged 5 years or younger.
And, vaccine ADEs impacted 3.7 percent for those aged 6-19 years.
This study evaluated data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project, which collates ADEs from a stratified national sample of hospital emergency departments (EDs).
Both prescribed and over-the-counter drugs as well as vaccines, nutritional supplements and vitamins, and homeopathic products were included in this study.
The mechanism of ADE, such as dosing or scheduling error, route error, incorrect drug administration, ingestion, or allergic reaction, was recorded for each ADE.
Additionally, among children aged 19 years or younger, antibiotics were among the most frequent drugs associated with ADEs, led by amoxicillin at 21 percent of ADEs.
Moreover, the inadvertent ingestion of drugs accounted for almost 5 percent of ADEs among all children, pointing out the need to remind parents about safe drug storage.
Based on data from 42,585 cases, an estimated 4.0 percent of ED visits for adverse drug events occurred per 1,000 individuals annually in 2013 and 2014.
Previous studies using pharmacist case review to identify adverse drug events resulting in ED visits have found additional events and drugs that ED physicians did not document.
However, early pharmacist-led medication review was associated with reduced hospital-bed utilization compared to usual care among high-risk patients under 80 years of age, but not among those who were older.
The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program run by CDC and the FDA.
VAERS was created in 1990 in response to the National Childhood Vaccine Injury Act. If any health problem happens after vaccination, pharmacists, doctors, nurses, and any member of the general public can submit a report to VAERS.
This study was funded by the US federal government. Disclosure: William T. Basco, Jr., MD, MS, Professor, Department of Pediatrics, Medical University of South Carolina (MUSC); Director, Division of General Pediatrics, Department of Pediatrics, MUSC Children's Hospital, Charleston, South Carolina, has disclosed no relevant financial relationships.
Corresponding Author: Nadine Shehab, PharmD, MPH, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, [email protected].
- Impact of early in-hospital medication review by clinical pharmacists on health services utilization
- US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014
- Vaccine Adverse Events: Separating Myth from Reality
- Pharmacist-led interventions to reduce unplanned admissions for older people: a systematic review and meta-analysis of randomise
- Vaccine Adverse Event Reporting System (VAERS)